Atria Wealth Solutions’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,709
| Closed | -$686K | – | 1506 |
|
|
2025
Q1 | $686K | Buy |
+9,709
| New | +$686K | 0.01% | 1038 |
|
|
2024
Q3 | – | Sell |
-2,542
| Closed | -$209K | – | 1910 |
|
|
2024
Q2 | $209K | Sell |
2,542
-7,296
| -74% | -$601K | ﹤0.01% | 1723 |
|
|
2024
Q1 | $859K | Buy |
9,838
+109
| +1% | +$9.52K | 0.01% | 973 |
|
|
2023
Q4 | $938K | Buy |
9,729
+153
| +2% | +$14.8K | 0.01% | 883 |
|
|
2023
Q3 | $847K | Buy |
9,576
+461
| +5% | +$40.8K | 0.01% | 884 |
|
|
2023
Q2 | $790K | Buy |
9,115
+631
| +7% | +$54.7K | 0.01% | 946 |
|
|
2023
Q1 | $825K | Buy |
8,484
+1,566
| +23% | +$152K | 0.01% | 872 |
|
|
2022
Q4 | $716K | Sell |
6,918
-176
| -2% | -$18.2K | 0.01% | 911 |
|
|
2022
Q3 | $601K | Sell |
7,094
-3,224
| -31% | -$273K | 0.01% | 925 |
|
|
2022
Q2 | $855K | Buy |
10,318
+2,206
| +27% | +$183K | 0.02% | 735 |
|
|
2022
Q1 | $625K | Buy |
+8,112
| New | +$625K | 0.01% | 940 |
|